How to Increase Motivation & Drive

The episode opens by placing motivation inside a month-long series on the neuroscience of emotions. The host, who introduces himself as Andrew Huberman, a professor of neurobiology and ophthalmology at Stanford School of Medicine, notes that the podcast is separate from his teaching and research roles there. The stated agenda is broad: pleasure and reward, addiction and the addictive properties of certain substances, how to break free of addiction, and the neurochemistry of drive and mindset. Each theme, he acknowledges, could fill its own month, and a full month on addiction is promised for later, with a guest who will cover clinical practice.

Motivation is framed as fundamental to daily life: it is what gets a person out of bed and what sustains pursuit of short- and long-term goals. The discussion ties it closely to movement. The same molecule, dopamine, is described as responsible both for the sense of motivation and for movement, even though the chemical that actually makes muscles contract is acetylcholine, which in the brain is linked to focus. Whether someone wants to move, or wants to overcome social, financial or time barriers, is presented as depending on dopamine.

So, if ever there was a double-edged blade in the world of neuroscience, it's dopamine.

That double edge is the episode's central tension: dopamine sits at the center of many great things in life and also of addiction and certain forms of mental disease. The promised tools come with a caveat. Supplementation will be discussed, but simply increasing dopamine is described as sometimes appropriate and sometimes the wrong thing to do. The larger emphasis is on what is called dopamine scheduling, the idea that how a person lives and conceptualizes goals can predict whether they keep pursuing those goals, succeed, or quit. The argument is that understanding the system lets you leverage it, whereas not understanding it means "the rest of the world is going to control your dopamine schedules." The tools are claimed to apply across ages, from five to 80 years old.

The basic science starts with history. Dopamine was discovered in the late 1950s as the precursor from which epinephrine, or adrenaline, is made. The host stresses that this matters because dopamine is now usually thought of as the molecule of reward and pleasure, yet it is also the substrate for epinephrine, which in the brain is called epinephrine rather than adrenaline. Epinephrine is described as getting us into action by changing blood vessels, the heart, and other organs and tissues in ways that bias us toward movement; listeners are pointed to an earlier episode on mastering stress for more detail.

Dopamine, however, is not always converted to epinephrine and does a lot on its own. It is released from several sites in the brain and body, but the focus here is the reward pathway, also called the mesolimbic reward pathway, presented as central both to the desire to act and to addiction to substances or behaviors.

The anatomy as described: - The ventral tegmental area (VTA), deep in the brain, contains neurons whose axons release dopamine onto the nucleus accumbens. - Together, the VTA and nucleus accumbens form the core of the reward pathway and of motivation for anything, likened to an accelerator that biases a person toward action. - The prefrontal cortex, behind the forehead and associated with decision-making, executive function and planning, acts as a brake controlling when and how much dopamine is released. - Humans are described as having a lot of prefrontal cortex compared with other animals; without that brake, a person would be "purely a pleasure-seeking animal."

Without the brake, the episode says, there would be no basis for regulating behavior aimed at getting things that feel good. This leads to the main conceptual claim: motivation is a two-part process that balances pleasure and pain, not just a drive toward pleasure, even though dopamine is indeed released from the VTA at the nucleus accumbens when we experience things we like.

To make this concrete, the host describes firing rates. At rest, such as lying in bed deciding whether to get up, the reward pathway is said to fire, meaning electrical activity in the neurons, at about three or four times per second. In that state a person feels okay, neither depressed nor highly motivated. When someone becomes excited in anticipation of something, before receiving any reward, the rate is said to jump to 30 or 40 times.

This increase creates a desire to move toward whatever is being craved. The key reframing is that dopamine is responsible for wanting and craving, which the host contrasts with the usual description of dopamine as being about pleasure. Dopamine is released in response to sex, food and many other things, but it is "mostly released in anticipation and craving for a particular thing," narrowing focus onto the object of desire. That object can be trivial or significant: a cup of coffee, a board meeting, a final exam, or a person one is excited to see.

Dopamine doesn't care about what you're craving, it just releases at a particular rate.

The episode then compares how much dopamine different experiences release, while noting that the figures are approximate and "these aren't exact numbers." Neurons are said to fire at a low rate until a person starts thinking about something they want, such as chocolate, a steak or a plate of pasta.

Approximate increases in reward-pathway dopamine as stated: - Eating a desired food: about 50% above baseline, with firing going from three or four per second to six or 10 per second. - Sex: about 100%, roughly doubling levels. - Nicotine, as in cigarettes or supplemental forms: about 150% above baseline, within seconds. - Cocaine and amphetamine: a thousandfold, within about 10 seconds of consuming the drug.

There is an internal inconsistency in the transcript: nicotine is first given as "about 150% above baseline" and then restated as "150 times over baseline" when contrasted with sex and food. The percentage framing matches the surrounding comparisons, but the source itself states both.

Anticipation itself is said to drive release: just thinking about food, sex, nicotine, cocaine or amphetamine can increase dopamine to the same degree as consuming them, though the host immediately qualifies this with "it depends." A person addicted to cocaine cannot raise dopamine a thousandfold just by thinking about it; the increase is much lower, but enough to set them on a motivational track toward the drug.

The evolutionary argument is that this circuitry did not evolve to produce addiction but to motivate behavior toward goals such as water when thirsty and sex for reproduction. Estrogen and testosterone are flagged as hormones that bias dopamine release, to be discussed later. Cocaine and amphetamine are called disastrous for most people because they release so much dopamine that they create closed loops in which people crave only the drug. Most things do not release that much.